Capital Ideas Podcast Rob Lovelace on the year ahead (2026 edition)
24 snips
Feb 12, 2026 Rob Lovelace, a long-tenured global equities portfolio manager, and David Polak, an investment director focused on multinationals and financials, discuss the 2026 outlook. They cover shifting global trade patterns, why non-U.S. markets led in 2025, the tech stack and AI in biotech, rising bank margins in Europe, and the New Geography of Investing.
AI Snips
Chapters
Transcript
Episode notes
AI Could Accelerate Drug Discovery
- Healthcare advances (DNA, AI in drug discovery) could materially improve drug success rates and speed discovery.
- Even with pricing headwinds, long-term government and private investment underpin health-sector innovation.
Banks Re-Emerge As Winners
- Higher interest rates revived bank profitability, making financials an unexpected 2025 winner.
- Selectivity matters: pick banks with better management, data and AI adoption to capture continuing upside.
Expect AI To Shift, Not Eliminate, Work
- Don't assume AI will eliminate demand for consultants or coders; expect work to shift not vanish.
- Monitor companies' business-mix changes and favour those that pivot into higher-value services.